Manipal Health Enterprises Ltd. is reportedly reducing its initial public offering valuation to $8.3 billion as it prepares to launch the share sale in the week beginning July 27.
The Temasek Holdings-backed operator aims to raise up to ₹11,000 crore through the offering, which is still on track to be India’s largest IPO of 2026 so far, surpassing SBI Funds Management Ltd.’s $1 billion listing earlier this week.
The valuation adjustment comes shortly after India’s securities regulator, SEBI, granted final approval for the IPOs of both Manipal Health Enterprises and RentoMojo, clearing the path for a combined capital raise of approximately ₹8,150 crore from the two entities.
The regulatory green light had previously set expectations for a robust debut, but the reported cut in valuation suggests a recalibration of pricing strategy in the current market environment.
For investors, the move signals a potential shift in appetite for large-cap healthcare listings in India.
While the company retains its position as the year’s biggest planned listing, the lower valuation may reflect broader caution among institutional buyers or a strategic decision to ensure full subscription.